Mark Nolan

627 total citations
29 papers, 417 citations indexed

About

Mark Nolan is a scholar working on Cardiology and Cardiovascular Medicine, Radiology, Nuclear Medicine and Imaging and Surgery. According to data from OpenAlex, Mark Nolan has authored 29 papers receiving a total of 417 indexed citations (citations by other indexed papers that have themselves been cited), including 24 papers in Cardiology and Cardiovascular Medicine, 9 papers in Radiology, Nuclear Medicine and Imaging and 3 papers in Surgery. Recurrent topics in Mark Nolan's work include Cardiovascular Function and Risk Factors (17 papers), Cardiac Imaging and Diagnostics (9 papers) and Heart Failure Treatment and Management (8 papers). Mark Nolan is often cited by papers focused on Cardiovascular Function and Risk Factors (17 papers), Cardiac Imaging and Diagnostics (9 papers) and Heart Failure Treatment and Management (8 papers). Mark Nolan collaborates with scholars based in Australia, United States and Canada. Mark Nolan's co-authors include Thomas H. Marwick, Kazuaki Negishi, Hong Yang, Ying Wang, S. Ramkumar, Quan Huynh, David Russell, Makoto Saito, Paaladinesh Thavendiranathan and Tomoko Negishi and has published in prestigious journals such as Circulation, Journal of the American College of Cardiology and Hypertension.

In The Last Decade

Mark Nolan

23 papers receiving 410 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Mark Nolan Australia 11 361 140 42 37 30 29 417
Frants Pedersen Denmark 10 332 0.9× 79 0.6× 37 0.9× 95 2.6× 50 1.7× 17 440
Akif Arslan Türkiye 11 195 0.5× 39 0.3× 20 0.5× 57 1.5× 26 0.9× 32 339
Elaine Tallon Ireland 7 408 1.1× 35 0.3× 63 1.5× 38 1.0× 46 1.5× 7 460
Ömer Gedikli Türkiye 14 299 0.8× 61 0.4× 18 0.4× 60 1.6× 29 1.0× 35 390
Apurva Motivala United States 10 231 0.6× 90 0.6× 29 0.7× 92 2.5× 23 0.8× 17 383
Dai-Yin Lu Taiwan 11 293 0.8× 52 0.4× 10 0.2× 63 1.7× 20 0.7× 24 373
Manvir Hayer United Kingdom 10 198 0.5× 117 0.8× 12 0.3× 61 1.6× 52 1.7× 19 336
Wunan Zhou United States 12 138 0.4× 124 0.9× 21 0.5× 75 2.0× 61 2.0× 30 371
Ioannis Ntalas Greece 11 402 1.1× 149 1.1× 20 0.5× 70 1.9× 57 1.9× 23 516
Nikos T. Kouris Greece 8 197 0.5× 55 0.4× 12 0.3× 48 1.3× 89 3.0× 21 322

Countries citing papers authored by Mark Nolan

Since Specialization
Citations

This map shows the geographic impact of Mark Nolan's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mark Nolan with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mark Nolan more than expected).

Fields of papers citing papers by Mark Nolan

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Mark Nolan. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mark Nolan. The network helps show where Mark Nolan may publish in the future.

Co-authorship network of co-authors of Mark Nolan

This figure shows the co-authorship network connecting the top 25 collaborators of Mark Nolan. A scholar is included among the top collaborators of Mark Nolan based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Mark Nolan. Mark Nolan is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
2.
Sharman, James E., Petr Otáhal, Michael Stowasser, et al.. (2024). Blood Pressure Lowering in Patients With Central Hypertension: A randomized Clinical Trial. Hypertension. 81(6). 1400–1409. 2 indexed citations
3.
Nolan, Mark, et al.. (2023). Screening for Coronary Artery Disease in Cancer Survivors. JACC CardioOncology. 5(1). 22–38. 40 indexed citations
4.
Ramkumar, S., Hong Yang, Mark Nolan, et al.. (2021). The importance of calibration method in determining the association between central blood pressure with left ventricular and left atrial strain. International journal of cardiac imaging. 38(3). 589–600. 2 indexed citations
5.
Nolan, Mark, Evangelos K. Oikonomou, Candice K. Silversides, et al.. (2020). Impact of Cancer Therapy-Related Cardiac Dysfunction on Risk of Heart Failure in Pregnancy. JACC CardioOncology. 2(2). 153–162. 15 indexed citations
6.
Kawakami, Hiroshi, S. Ramkumar, Mark Nolan, et al.. (2019). Left Atrial Mechanical Dispersion Assessed by Strain Echocardiography as an Independent Predictor of New-Onset Atrial Fibrillation: A Case-Control Study. Journal of the American Society of Echocardiography. 32(10). 1268–1276.e3. 45 indexed citations
7.
Wang, Ying, Hong Yang, Quan Huynh, et al.. (2018). Diagnosis of Nonischemic Stage B Heart Failure in Type 2 Diabetes Mellitus. JACC. Cardiovascular imaging. 11(10). 1390–1400. 68 indexed citations
8.
Wang, Ying, Hong Yang, Mark Nolan, et al.. (2018). Association of depression with evolution of heart failure in patients with type 2 diabetes mellitus. Cardiovascular Diabetology. 17(1). 19–19. 22 indexed citations
9.
Ramkumar, S., Ying Wang, Nicholas D’Elia, et al.. (2017). Abstract 14994: Association Between Low Socio-Economic Status and Risk of Incident Atrial Fibrillation. Circulation. 1 indexed citations
10.
Ramkumar, S., Hong Yang, Ying Wang, et al.. (2017). Association of the Active and Passive Components of Left Atrial Deformation with Left Ventricular Function. Journal of the American Society of Echocardiography. 30(7). 659–666. 53 indexed citations
11.
Yang, Hong, Thomas H. Marwick, Ying Wang, et al.. (2017). Association Between Electrocardiographic and Echocardiographic Markers of Stage B Heart Failure and Cardiovascular Outcome. ESC Heart Failure. 4(4). 417–431. 6 indexed citations
12.
Yang, Hong, Kazuaki Negishi, Ying Wang, Mark Nolan, & Thomas H. Marwick. (2017). Imaging-Guided Cardioprotective Treatment in a Community Elderly Population of Stage B Heart Failure. JACC. Cardiovascular imaging. 10(3). 217–226. 23 indexed citations
13.
Pathan, Faraz, Nicholas D’Elia, Mark Nolan, Thomas H. Marwick, & Kazuaki Negishi. (2016). NORMAL RANGES OF LEFT ATRIAL STRAIN BY SPECKLE TRACKING ECHOCARDIOGRAPHY: A SYSTEMATIC REVIEW AND META-ANALYSIS OF 1,789 HEALTHY SUBJECTS. Journal of the American College of Cardiology. 67(13). 1582–1582. 2 indexed citations
14.
Ramkumar, S., Hong Yang, Ying Wang, et al.. (2016). Relation of Functional Status to Risk of Development of Atrial Fibrillation. The American Journal of Cardiology. 119(4). 572–578. 2 indexed citations
15.
Yang, Hong, Kazuaki Negishi, Ying Wang, et al.. (2016). Echocardiographic Screening for Non-Ischaemic Stage B Heart Failure in the Community. European Journal of Heart Failure. 18(11). 1331–1339. 66 indexed citations
16.
Nolan, Mark, David Russell, Kazuaki Negishi, & Thomas H. Marwick. (2016). Meta-Analysis of Association Between Mediastinal Radiotherapy and Long-Term Heart Failure. The American Journal of Cardiology. 118(11). 1685–1691. 9 indexed citations
17.
Wang, Ying, Hong Yang, Mark Nolan, et al.. (2015). Association of waist circumference with impaired six-minute walk in type 2 diabetes mellitus is independent of cardiac function. Journal of Diabetes and its Complications. 30(3). 542–544.
18.
Nolan, Mark, David Russell, & Thomas H. Marwick. (2015). Long-term Risk of Heart Failure and Myocardial Dysfunction After Thoracic Radiotherapy: A Systematic Review. Canadian Journal of Cardiology. 32(7). 908–920. 25 indexed citations
19.
Nolan, Mark. (2012). EMEA approved new drugs: Vinflunine: Figure 1. European Journal of Hospital Pharmacy. 19(1). 26–27. 1 indexed citations
20.
Nolan, Mark, et al.. (1986). Frontiers of technology. 24. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026